| pubmed-article:20886110 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20886110 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
| pubmed-article:20886110 | lifeskim:mentions | umls-concept:C0033572 | lld:lifeskim |
| pubmed-article:20886110 | lifeskim:mentions | umls-concept:C1257975 | lld:lifeskim |
| pubmed-article:20886110 | lifeskim:mentions | umls-concept:C1441547 | lld:lifeskim |
| pubmed-article:20886110 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:20886110 | pubmed:dateCreated | 2010-10-4 | lld:pubmed |
| pubmed-article:20886110 | pubmed:abstractText | Prostate cancer recurrence involves increased growth of cancer epithelial cells, as androgen dependent prostate cancer progresses to castrate resistant prostate cancer (CRPC) following initial therapy. Understanding CRPC prostate regrowth will provide opportunities for new cancer therapies to treat advanced disease. | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20886110 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20886110 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20886110 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20886110 | pubmed:issn | 1932-6203 | lld:pubmed |
| pubmed-article:20886110 | pubmed:author | pubmed-author:LiXiaohongX | lld:pubmed |
| pubmed-article:20886110 | pubmed:author | pubmed-author:SherrillTaylo... | lld:pubmed |
| pubmed-article:20886110 | pubmed:author | pubmed-author:BhowmickNeil... | lld:pubmed |
| pubmed-article:20886110 | pubmed:author | pubmed-author:PlacencioVero... | lld:pubmed |
| pubmed-article:20886110 | pubmed:author | pubmed-author:FritzGloriaG | lld:pubmed |
| pubmed-article:20886110 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20886110 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:20886110 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20886110 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20886110 | pubmed:pagination | e12920 | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:meshHeading | pubmed-meshheading:20886110... | lld:pubmed |
| pubmed-article:20886110 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20886110 | pubmed:articleTitle | Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. | lld:pubmed |
| pubmed-article:20886110 | pubmed:affiliation | Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee, United States of America. | lld:pubmed |
| pubmed-article:20886110 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20886110 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:20886110 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:21813 | entrezgene:pubmed | pubmed-article:20886110 | lld:entrezgene |
